Michelle Worst Honored With 2025 HOPA Volunteer Award
March 10, 2025 | CME, HOPA2025, HemOnc, OncologyEducation, VolunteerAward
Medscape is proud to highlight Michelle A. Worst, PharmD, BCOP, MBA, CHCP, Senior Director and Team Lead of Clinical Strategy in Hematology/Oncology, for her well-deserved recognition as the recipient of the 2025 HOPA Volunteer Award. Michelle is being honored for her exceptional dedication through committee and task force contributions, as well as representing the Hematology/Oncology Pharmacy Association (HOPA) at external events. Her commitment to hematology/oncology and her efforts in advancing education and collaboration make her a true leader in the field.
Reflecting on this recognition, Michelle shared, “My work in hematology/oncology is deeply personal, and I am passionate about advancing education, fostering collaboration, and ensuring we continue to elevate the standard of care for patients. Through my involvement in HOPA—whether shaping conference content, mentoring colleagues, or strategizing for the organization’s future—I’ve been fortunate to work alongside inspiring professionals who share a common goal: making a meaningful impact in oncology. I look forward to continuing this journey, driving innovation, and supporting the next generation of leaders in our field.”
Michelle will be formally honored at the 2025 HOPA Annual Conference during the Annual Member Business Meeting on Thursday, April 10th, at 10:50 AM PST.
At Medscape, we are committed to being the thread that runs through healthcare, connecting professionals with trusted education and insights that drive meaningful change. Our collective voice is one of credibility, passion, and an unwavering dedication to oncology education. Michelle’s contributions exemplify the spirit of volunteerism that strengthens the oncology community, and we celebrate her dedication to improving patient care. As we honor her remarkable achievements, we also look forward to our continued engagement at HOPA 2025.
Medscape will extend its presence at the HOPA Conference with our symposium:
- Pharmacist Perspectives: Navigating BCMA-Directed Therapies in Multiple Myeloma on Friday, April 11 from 6:30 PM – 7:30 PM.
Join us as we celebrate Michelle’s accomplishments and continue to advance oncology education together. Congratulations, Michelle, on this well-earned recognition!
For more information on Hematology/ Oncology Education please contact: Jelena Spyropoulos
This content was provided by Medscape Education
Company Details
Latest Content from Medscape Education
The Power of Patient Insights to Improve Cancer Care
Two global patient advocacy groups—The Lymphoma Coalition and Lung Cancer Europe— are compiling data from their communities on the real-world experience of living with cancer. What the data reveals sometimes...
Medscape Education Continues Its Patient-Centric Mission at EHA 2024
Anticipation is building at Medscape Education as the team prepares for the EHA 2024 Congress. Medscape Education is excited to announce a significant presence during the congress including a Medscape...
Getting in-sync with Public Health at SYNC 2024
Medscape Education is bringing its public health efforts to Washington, DC for the SYNC conference on HIV, HCV, STIs, Harm Reduction, and LGBTQ health. During the conference, Lindsey will present...
Medscape Education and KDIGO Nephrology Collaboration Accelerates Improvements to Patient Care
Ahead of the 61st European Renal Association (ERA) Congress, Medscape Education and KDIGO (Kidney Disease: Improving Global Outcomes) announce an educational collaboration through a series of webinars to improve anemia-related...
Medscape Brings Impact and Data to ESPGHAN
The ESPGHAN Congress in Milan was full of impact as Medscape Education Global presented 5 scientific posters examining the outcomes of their education. The posters detailed the impact Medscape Education...
Empowering Nurses Through Education
Nurse education is powerful and makes an impact.
Pioneering Paths: Women Leadership in Rare Disease
Rare diseases are often thought of as affecting one in 100,000 or one in 1,000,000 people, and that is true for some conditions. But there are many rare diseases that...
TRANSFORMING CME IMPACT: MEDSCAPE’S GAME-CHANGING APPROACH
It’s time for the CME industry to evolve. During recent years, access to data, modern technologies, and methodologies have allowed for deeper analysis of data and a better understanding of...
Why Women in Medicine Should Embrace Social Media
Of course social media has its downside. But online platforms are a powerful tool for women in medicine in terms of forming communities, fighting misinformation, amplifying one another, and galvanizing...
Exceptional Impact Presented at ECCMID 2024
The ECCMID conference in Barcelona, Spain marked the start of Medscape’s publication season in Europe. With three posters being presented at the conference, Medscape shared highlights from the powerful impact...